Literature DB >> 2542952

Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis.

P A de Viragh1, K G Haglid, M R Celio.   

Abstract

The influence of chronic vitamin D3 application on the concentration of the four calcium-binding proteins parvalbumin, the 28-kDa calbindin-D, calmodulin, and S-100 was studied in various brain regions and in the kidney. Young rats were administered daily 20,000 international units of vitamin D3 per kg (body weight) over a period of 4 months. This chronic treatment resulted in a clinically mild hypervitaminosis that did not affect the content of calmodulin, the 28-kDa calbindin-D, and S-100. Also the concentration of parvalbumin in the cerebral cortex, hippocampus, and kidney remained unchanged. On the other hand, parvalbumin was increased about 50% in the caudate putamen of hypervitaminotic animals as compared to controls. Our results indicate that the metabolism of parvalbumin in the caudate putamen can be influenced by variations of the blood level of this steroid hormone.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542952      PMCID: PMC287246          DOI: 10.1073/pnas.86.10.3887

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  THE PREPARATION OF H3-VITAMINS D2 AND D3--THEIR LOCALIZATION IN THE RAT.

Authors:  A W NORMAN; H F DELUCA
Journal:  Biochemistry       Date:  1963 Sep-Oct       Impact factor: 3.162

2.  Immunolocalization of parvalbumin.

Authors:  C W Heizmann; M R Celio
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Studies on the mode of action of calciferol. XIII. Development of a radioimmunoassay for vitamin D-dependent chick intestinal calcium-binding protein and tissue distribution.

Authors:  S Christakos; E J Friedlander; B R Frandsen; A W Norman
Journal:  Endocrinology       Date:  1979-05       Impact factor: 4.736

4.  Localization of salmon calcitonin binding sites in rat brain by autoradiography.

Authors:  H Henke; P H Tobler; J A Fischer
Journal:  Brain Res       Date:  1983-08-08       Impact factor: 3.252

5.  Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid.

Authors:  W E Stumpf; M Sar; F A Reid; Y Tanaka; H F DeLuca
Journal:  Science       Date:  1979-12-07       Impact factor: 47.728

6.  Chick brain calcium binding protein: response to cholecalciferol and some developmental aspects.

Authors:  A N Taylor
Journal:  J Nutr       Date:  1977-03       Impact factor: 4.798

7.  Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier.

Authors:  W M Pardridge; R Sakiyama; W A Coty
Journal:  J Neurochem       Date:  1985-04       Impact factor: 5.372

8.  Parvalbumin in rat kidney. Purification and localization.

Authors:  P R Schneeberger; C W Heizmann
Journal:  FEBS Lett       Date:  1986-05-26       Impact factor: 4.124

9.  Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain.

Authors:  M Gascon-Barré; P M Huet
Journal:  Am J Physiol       Date:  1983-03

10.  Analysis of rat vitamin D-dependent calbindin-D28k gene expression.

Authors:  S Varghese; S Lee; Y C Huang; S Christakos
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

View more
  19 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

Review 2.  Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia.

Authors:  Michael J Berridge
Journal:  Prion       Date:  2012-08-16       Impact factor: 3.931

3.  Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.

Authors:  Wayne A Cass; Laura E Peters; Anita M Fletcher; David M Yurek
Journal:  Neurochem Res       Date:  2014-05-25       Impact factor: 3.996

4.  Vitamin D receptor gene polymorphisms and cognitive decline in Parkinson's disease.

Authors:  Nicole M Gatto; Kimberly C Paul; Janet S Sinsheimer; Jeff M Bronstein; Yvette Bordelon; Rebecca Rausch; Beate Ritz
Journal:  J Neurol Sci       Date:  2016-09-11       Impact factor: 3.181

5.  Vitamin D Levels and the Risk of Cognitive Decline in Chinese Elderly People: the Chinese Longitudinal Healthy Longevity Survey.

Authors:  David B Matchar; Choy-Lye Chei; Zhao-Xue Yin; Victoria Koh; Bibhas Chakraborty; Xiao-Ming Shi; Yi Zeng
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-07-12       Impact factor: 6.053

Review 6.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

7.  Vitamin D target systems in the brain of the green lizard Anolis carolinensis.

Authors:  H J Bidmon; W E Stumpf
Journal:  Anat Embryol (Berl)       Date:  1996-02

Review 8.  Possibility of a new anti-alzheimer's disease pharmaceutical composition combining memantine and vitamin D.

Authors:  Cédric Annweiler; Olivier Beauchet
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

Review 9.  Vitamin D as a potential therapy in amyotrophic lateral sclerosis.

Authors:  Alexandro Gianforcaro; Mazen J Hamadeh
Journal:  CNS Neurosci Ther       Date:  2014-02       Impact factor: 5.243

Review 10.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.